• SUBSCRIBE
    • Action Alerts PLUS
    • Real Money
    • Real Money Pro
    • Quant Ratings
    • Retirement Daily
    • Stocks Under $10
    • Trifecta Stocks
    • Top Stocks
    • Real Money Pro Portfolio
    • Chairman's Club
    • Compare All
  • JIM CRAMER
    • Action Alerts PLUS
    • Cramer's Blog
    • Cramer's Monthly Call
    • Jim Cramer's Best Stocks
    • Cramer's Articles
    • Mad Money
    • 25 Rules for Investing
    • 10 Commandments
  • INVESTING
    • Bitcoin
    • Cannabis
    • Cryptocurrency
    • ETFs
    • Earnings
    • Fixed Income
    • Funds
      • Bond Funds
      • Index Funds
      • Mutual Funds
    • Futures
    • Options
    • REITs
    • Stocks
      • Penny Stocks
      • Preferred Stocks
  • PERSONAL FINANCE
    • Credit Cards
    • Debt Management
    • Education
    • Employee Benefits
    • Insurance
      • Car Insurance
      • Disability Insurance
      • Health Insurance
      • Home Insurance
      • Life Insurance
    • Mortgages
    • Real Estate
    • Savings
    • Taxes
  • RETIREMENT
    • 401K
    • Estate Planning
    • IRAs
      • Roth IRAs
    • Social Security
  • TECHNOLOGY
    • Cybersecurity
  • MARKETS
    • Bankruptcy
    • Commodities
      • Gold
      • Oil
    • Corporate Governance
    • Currencies
    • Emerging Markets
    • IPOs
    • Mergers and Acquisitions
    • Rates and Bonds
      • Junk Bonds
      • Treasury Bonds
    • Regulation
  • HOW-TO
  • VIDEO
    • Audio
  • Courses
    • Personal Finance Essentials
    • Fundamentals of Investing
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
  • Privacy Settings
  • Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account
TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
  • Alerts
  • |
  • Newsletters
  • Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

AbbVie Affirmed Overweight at Piper Jaffray on Potential of Arthritis Drug
STOCKS

AbbVie Affirmed Overweight at Piper Jaffray on Potential of Arthritis Drug

  • By Tony Owusu
  • Dec 3, 2019 10:06 AM EST
Dow Futures Push Further Into Record Highs as Trump Signals China Trade Progress
JIM CRAMER

Tsunami of Innovation: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Nov 21, 2019 8:59 PM EST
AbbVie, Nokia, Lululemon Athletica: 'Mad Money' Lightning Round
JIM CRAMER

AbbVie, Nokia, Lululemon Athletica: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Nov 21, 2019 8:39 PM EST
Abbott Labs Taps Operating Chief Robert Ford as CEO, Succeeding Miles White
CORPORATE GOVERNANCE

Abbott Labs Taps Operating Chief Robert Ford as CEO, Succeeding Miles White

  • By Rob Daniel
  • Nov 13, 2019 10:54 AM EST
AbbVie Selling Up to $28 Billion in Bonds to Acquire Allergan: Report
INVESTING

AbbVie Selling Up to $28 Billion in Bonds to Acquire Allergan: Report

  • By Scott Van Voorhis
  • Nov 12, 2019 10:00 AM EST
Allergan Tops Q3 Earnings, Bumps 2019 Sales Guidance Amid AbbVie Takeover
EARNINGS

Allergan Tops Q3 Earnings, Bumps 2019 Sales Guidance Amid AbbVie Takeover

  • By Martin Baccardax
  • Nov 5, 2019 9:40 AM EST
AbbVie Affirmed Overweight at Piper Jaffray on Potential of Arthritis Drug
INVESTING

AbbVie Posts Stronger-Than-Expected Earnings, Lifts Forecast

  • By M. Corey Goldman
  • Nov 1, 2019 9:35 AM EDT
AbbVie Hits Another Home Run, Even as Humira Sales Drop
EARNINGS

AbbVie Hits Another Home Run, Even as Humira Sales Drop

  • Nov 1, 2019 9:33 AM EDT
Jobs Report, Exxon, Pinterest, Amgen, U.S. Steel - 5 Things You Must Know Friday
MARKETS

Jobs Report, Exxon, Pinterest, Amgen, U.S. Steel - 5 Things You Must Know Friday

  • By Joseph Woelfel
  • Nov 1, 2019 7:01 AM EDT
Fed Watch Begins: Jim Cramer Talks Trump's Tweets and Facebook's Cryptocurrency
JIM CRAMER

Forget About the Fed: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Oct 30, 2019 9:43 PM EDT
Good News Is Good News: Cramer's 'Mad Money' Recap (Tuesday 11/12/19)
JIM CRAMER

Safe From Trade Troubles: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Oct 16, 2019 9:28 PM EDT
U.S. Stock Futures Improve Amid Potential Thaw in China Trade Tensions
JIM CRAMER

Great Investors Need Good Judgment: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Oct 15, 2019 6:59 PM EDT
You Can Get the Best Dividends on the Market in These Sectors: Goldman Sachs
PERSONAL FINANCE

Dividend Investing: What Is It and How Does It Work?

  • By Roger Wohlner
  • Sep 23, 2019 12:36 PM EDT
Small Chinese Firms May Have Harder Time Getting Listed on Nasdaq: Report
JIM CRAMER

Don't Wait for China: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Sep 22, 2019 5:34 PM EDT
Amgen Looks Attractive After Its Recent Pullback
STOCKS

Amgen Looks Attractive After Its Recent Pullback

  • By Nicholas Ward
  • Sep 22, 2019 5:33 PM EDT
Tesla, Facebook and ZTE - 5 Things You Must Know Before the Market Opens
MARKETS

Broadcom, WeWork, Dow Futures, China Trade, Cloudflare - 5 Things You Must Know

  • By Joseph Woelfel
  • Sep 13, 2019 6:37 AM EDT
AbbVie, Nokia, Lululemon Athletica: 'Mad Money' Lightning Round
MARKETS

AbbVie Stock Rises After UBS Upgrades To Buy

  • By Brenda Bouw
  • Sep 12, 2019 2:54 PM EDT
Aurora Cannabis the Latest Pot Company to Miss Earnings Estimates; Shares Tumble
CANNABIS

Aurora Cannabis Shares Drop Almost 10% in Late Trade After Quarterly Results

  • By Tom Bemis
  • Sep 11, 2019 6:02 PM EDT
As U.S. Interest Rates Head Lower, Here's What To Invest In
INVESTING

As U.S. Interest Rates Head Lower, Here's What To Invest In

  • By Jason Orestes
  • Sep 3, 2019 12:22 PM EDT
Allergan: Cramer's Top Takeaways
INVESTING

Allergan Reaches Settlement With Ohio Plaintiffs in Federal Opioid Litigation

  • By M. Corey Goldman
  • Aug 30, 2019 9:39 AM EDT
AbbVie, Nokia, Lululemon Athletica: 'Mad Money' Lightning Round
STOCKS

AbbVie Discontinues Phase III Trial of Drug to Treat Small-Cell Lung Cancer

  • By Tony Owusu
  • Aug 29, 2019 1:29 PM EDT
Union Pacific Shares Rise After Railroad Beats Earnings Estimates
JIM CRAMER

Union Pacific, Pfizer, Merck, AbbVie: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Aug 21, 2019 8:43 PM EDT
7 Consumer Stocks Goldman Sachs Thinks Have 25% Average Upside
JIM CRAMER

Taking a Cue From Retailers: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Aug 21, 2019 8:39 PM EDT
Aphria Soars, Other Pot Stocks Mixed Following Hostile $2 Billion Bid
CANNABIS

Cannabis Stocks Fall: Tilray Up 10.4%; General Cannabis Off 5.3%

  • By Tom Bemis
  • Aug 21, 2019 6:06 PM EDT
Tesla Stock Movements Not Making Any Sense? Join the Club, Morgan Stanley Says
STOCKS

Tesla Short-Sellers Are Up Some $3 Billion So Far in 2019

  • By Brenda Bouw
  • Aug 14, 2019 1:49 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2019 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.